{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T15:02:11Z","timestamp":1794668531422,"version":"4.9.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Long noncoding RNAs (lncRNAs) play important regulatory roles in a variety of pathological processes involving cancer. However, the exact molecular mechanisms of lncRNA regulation in endometrial carcinoma (EC) remain poorly defined. The aim of this study was to illustrate the mechanism of LINC00958 in regulating the function of IGF2BP3, an RNA binding protein involved in mRNA stability, and their clinical implications in EC. First, we investigated the clinical role of IGF2BP3 in EC and demonstrated its prognostic value. Loss-of-function and gain-of-function studies showed that IGF2BP3 promoted EC cell proliferation, migration and invasion. Then, we carried out RNA immunoprecipitation sequencing (RIP-seq) analysis, RNA pulldown and immunofluorescence-RNA fluorescence in situ hybridization to identify LINC00958 that interacted with IGF2BP3 in the cytoplasm of EC cells. Rescue experiments indicated that knockdown of LINC00958 partially offset the EC cell progression mediated by IGF2BP3. After that, RNA sequencing was used to screen out the downstream genes of IGF2BP3 and LINC00958. The results revealed that IGF2BP3 upregulated E2F3 expression by interacting with LINC00958. Furthermore, RNA stability assays demonstrated that silencing LINC00958 partially rescued the IGF2BP3-mediated promoting effect on the mRNA stability of E2F3. Collectively, this study suggests that LINC00958, as an oncogene, assists IGF2BP3 in stabilizing E2F3 mRNA and ultimately promotes EC progression, providing a promising therapeutic target for patients with EC.<\/jats:p>","DOI":"10.1038\/s41420-022-01045-x","type":"journal-article","created":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T12:03:44Z","timestamp":1654689824000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["IGF2BP3 enhances the mRNA stability of E2F3 by interacting with LINC00958 to promote endometrial carcinoma progression"],"prefix":"10.1038","volume":"8","author":[{"given":"Cuicui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanfei","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianing","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0271-8035","authenticated-orcid":false,"given":"Xiaoxin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,8]]},"reference":[{"key":"1045_CR1","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115\u201332.","journal-title":"CA Cancer J Clin"},{"key":"1045_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel RL, Miller KD. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7\u201334.","journal-title":"CA Cancer J Clin"},{"key":"1045_CR3","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.ygyno.2018.05.015","volume":"150","author":"RC Arend","year":"2018","unstructured":"Arend RC, Jones BA, Martinez A, Goodfellow P. Endometrial cancer: Molecular markers and management of advanced stage disease. Gynecologic Oncol. 2018;150:569\u201380.","journal-title":"Gynecologic Oncol"},{"key":"1045_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ygyno.2019.07.021","volume":"155","author":"AH Latham","year":"2019","unstructured":"Latham AH, Chen L, Hou JY, Tergas AI, Khoury-Collado F, St Clair CM, et al. Sequencing of therapy in women with stage III endometrial carcinoma receiving adjuvant combination chemotherapy and radiation. Gynecologic Oncol. 2019;155:13\u201320.","journal-title":"Gynecologic Oncol"},{"key":"1045_CR5","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.3802\/jgo.2019.30.e46","volume":"30","author":"C Di Tucci","year":"2019","unstructured":"Di Tucci C, Capone C. Immunotherapy in endometrial cancer: new scenarios on the horizon. J gynecologic Oncol. 2019;30:e46.","journal-title":"J gynecologic Oncol"},{"key":"1045_CR6","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1172\/JCI84421","volume":"126","author":"JR Evans","year":"2016","unstructured":"Evans JR, Feng FY, Chinnaiyan AM. The bright side of dark matter: lncRNAs in cancer. J Clin Investig. 2016;126:2775\u201382.","journal-title":"J Clin Investig"},{"key":"1045_CR7","doi-asserted-by":"crossref","unstructured":"Dong P, Xiong Y, Yue J, S JBH, Kobayashi N, Todo Y, et al. Exploring lncRNA-Mediated Regulatory Networks in Endometrial Cancer Cells and the Tumor Microenvironment: Advances and Challenges. Cancers. 2019;11:234.","DOI":"10.3390\/cancers11020234"},{"key":"1045_CR8","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.cell.2018.01.011","volume":"172","author":"F Kopp","year":"2018","unstructured":"Kopp F, Mendell JT. Functional Classification and Experimental Dissection of Long Noncoding RNAs. Cell 2018;172:393\u2013407.","journal-title":"Cell"},{"key":"1045_CR9","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.neo.2021.05.004","volume":"23","author":"JT Fan","year":"2021","unstructured":"Fan JT, Zhou ZY, Luo YL, Luo Q, Chen SB, Zhao JC, et al. Exosomal lncRNA NEAT1 from cancer-associated fibroblasts facilitates endometrial cancer progression via miR-26a\/b-5p-mediated STAT3\/YKL-40 signaling pathway. Neoplasia (N. Y, NY). 2021;23:692\u2013703.","journal-title":"Neoplasia (N. Y, NY)"},{"key":"1045_CR10","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.omtn.2021.04.011","volume":"24","author":"J Ma","year":"2021","unstructured":"Ma J, Kong FF, Yang D, Yang H, Wang C, Cong R, et al. lncRNA MIR210HG promotes the progression of endometrial cancer by sponging miR-337-3p\/137 via the HMGA2-TGF-beta\/Wnt pathway. Mol Ther Nucleic acids. 2021;24:905\u201322.","journal-title":"Mol Ther Nucleic acids"},{"key":"1045_CR11","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.canlet.2021.10.029","volume":"526","author":"K Zhang","year":"2021","unstructured":"Zhang K, Chen J, Li C, Yuan Y, Fang S, Liu W, et al. Exosome-mediated transfer of SNHG7 enhances docetaxel resistance in lung adenocarcinoma. Cancer Lett. 2021;526:142\u201354.","journal-title":"Cancer Lett"},{"key":"1045_CR12","doi-asserted-by":"publisher","first-page":"5358","DOI":"10.1038\/s41388-020-1338-9","volume":"39","author":"T Sun","year":"2020","unstructured":"Sun T, Wu Z, Wang X, Wang Y, Hu X, Qin W, et al. LNC942 promoting METTL14-mediated m(6)A methylation in breast cancer cell proliferation and progression. Oncogene. 2020;39:5358\u201372.","journal-title":"Oncogene."},{"key":"1045_CR13","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1007\/s00018-012-1186-z","volume":"70","author":"JL Bell","year":"2013","unstructured":"Bell JL, W\u00e4chter K, M\u00fchleck B, Pazaitis N, K\u00f6hn M, Lederer M, et al. Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression? Cell Mol life Sci: CMLS. 2013;70:2657\u201375.","journal-title":"Cell Mol life Sci: CMLS"},{"key":"1045_CR14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.canlet.2017.11.039","volume":"415","author":"HY Kim","year":"2018","unstructured":"Kim HY, Ha Thi HT, Hong S. IMP2 and IMP3 cooperate to promote the metastasis of triple-negative breast cancer through destabilization of progesterone receptor. Cancer Lett. 2018;415:30\u20139.","journal-title":"Cancer Lett"},{"key":"1045_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-017-0647-2","volume":"16","author":"Y Zhou","year":"2017","unstructured":"Zhou Y, Huang T, Siu HL, Wong CC, Dong Y, Wu F, et al. IGF2BP3 functions as a potential oncogene and is a crucial target of miR-34a in gastric carcinogenesis. Mol Cancer. 2017;16:77.","journal-title":"Mol Cancer"},{"key":"1045_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04006-0","volume":"9","author":"Z Li","year":"2018","unstructured":"Li Z, Zhang J, Liu X, Li S, Wang Q, Di C, et al. The LINC01138 drives malignancies via activating arginine methyltransferase 5 in hepatocellular carcinoma. Nat Commun. 2018;9:1572.","journal-title":"Nat Commun"},{"key":"1045_CR17","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","volume":"20","author":"H Huang","year":"2018","unstructured":"Huang H, Weng H, Sun W, Qin X, Shi H, Wu H, et al. Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat Cell Biol. 2018;20:285\u201395.","journal-title":"Nat Cell Biol"},{"key":"1045_CR18","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1158\/0008-5472.CAN-20-1619","volume":"81","author":"Y Gu","year":"2021","unstructured":"Gu Y, Niu S, Wang Y, Duan L, Pan Y, Tong Z, et al. DMDRMR-Mediated Regulation of m6A-Modified CDK4 by m6A Reader IGF2BP3 Drives ccRCC Progression. Cancer Res. 2021;81:923\u201334.","journal-title":"Cancer Res"},{"key":"1045_CR19","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","volume":"19","author":"DS Chandrashekar","year":"2017","unstructured":"Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi B, et al. UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses. Neoplasia (N. Y, NY). 2017;19:649\u201358.","journal-title":"Neoplasia (N. Y, NY)"},{"key":"1045_CR20","doi-asserted-by":"publisher","first-page":"D1251","DOI":"10.1093\/nar\/gkaa1006","volume":"49","author":"Y Gao","year":"2021","unstructured":"Gao Y, Shang S, Guo S, Li X, Zhou H, Liu H, et al. Lnc2Cancer 3.0: an updated resource for experimentally supported lncRNA\/circRNA cancer associations and web tools based on RNA-seq and scRNA-seq data. Nucleic acids Res. 2021;49:D1251\u2013D8.","journal-title":"Nucleic acids Res"},{"key":"1045_CR21","doi-asserted-by":"publisher","first-page":"e3345","DOI":"10.1002\/jgm.3345","volume":"23","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Qiao Z, Jiang J, Zhang J. LINC00958 promotes endometrial cancer cell proliferation and metastasis by regulating the miR-145-3p\/TCF4 axis. J Gene Med. 2021;23:e3345.","journal-title":"J Gene Med"},{"key":"1045_CR22","first-page":"6853","volume":"25","author":"QY Li","year":"2021","unstructured":"Li QY, Shen JQ, Li JH, Dai DF, Saeed M, Li CX. LINC00958\/miR-3174\/PHF6 axis is responsible for triggering proliferation, migration and invasion of endometrial cancer. Eur Rev Med Pharmacol Sci. 2021;25:6853\u201361.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1045_CR23","doi-asserted-by":"publisher","first-page":"109870","DOI":"10.1016\/j.biopha.2020.109870","volume":"125","author":"J Hu","year":"2020","unstructured":"Hu J, Shen J, Sun J. CDK4\/RB\/E2Fs axis as potential therapeutic target of endometrial cancer. Biomedicine Pharmacother = Biomedecine pharmacotherapie. 2020;125:109870.","journal-title":"Biomedicine Pharmacother = Biomedecine pharmacotherapie"},{"key":"1045_CR24","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41419-018-0556-3","volume":"9","author":"J Wan","year":"2018","unstructured":"Wan J, Liu H, Feng Q, Liu J, Ming L. HOXB9 promotes endometrial cancer progression by targeting E2F3. Cell Death Dis. 2018;9:509.","journal-title":"Cell Death Dis"},{"key":"1045_CR25","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1261\/rna.1175909","volume":"15","author":"D Weidensdorfer","year":"2009","unstructured":"Weidensdorfer D, St\u00f6hr N, Baude A, Lederer M, K\u00f6hn M, Schierhorn A, et al. Control of c-myc mRNA stability by IGF2BP1-associated cytoplasmic RNPs. RNA (N. Y, NY). 2009;15:104\u201315.","journal-title":"RNA (N. Y, NY)"},{"key":"1045_CR26","doi-asserted-by":"crossref","unstructured":"Samuels TJ, J\u00e4rvelin AI Imp\/IGF2BP levels modulate individual neural stem cell growth and division through myc mRNA stability. eLife. 2020;9:e51529.","DOI":"10.7554\/eLife.51529"},{"key":"1045_CR27","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/s41556-019-0311-8","volume":"21","author":"RW Yao","year":"2019","unstructured":"Yao RW, Wang Y, Chen LL. Cellular functions of long noncoding RNAs. Nat Cell Biol. 2019;21:542\u201351.","journal-title":"Nat Cell Biol"},{"key":"1045_CR28","doi-asserted-by":"crossref","unstructured":"Wang Y, Lu JH, Wu QN, Jin Y, Wang DS, Chen YX, et al. LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer. Mol Cancer. 2019;18:174.","DOI":"10.1186\/s12943-019-1105-0"},{"key":"1045_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0820-2","volume":"17","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Liu Y, Lin L, Huang Q, He W, Zhang S, et al. The lncRNA MACC1-AS1 promotes gastric cancer cell metabolic plasticity via AMPK\/Lin28 mediated mRNA stability of MACC1. Mol cancer. 2018;17:69.","journal-title":"Mol cancer"},{"key":"1045_CR30","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1038\/modpathol.3800960","volume":"20","author":"C Li","year":"2007","unstructured":"Li C, Zota V, Woda BA, Rock KL, Fraire AE, Jiang Z, et al. Expression of a novel oncofetal mRNA-binding protein IMP3 in endometrial carcinomas: diagnostic significance and clinicopathologic correlations. Mod Pathol. 2007;20:1263\u20138.","journal-title":"Mod Pathol"},{"key":"1045_CR31","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1016\/j.humpath.2012.12.003","volume":"44","author":"O Fadare","year":"2013","unstructured":"Fadare O, Liang SX, Crispens MA, Jones HW 3rd, Khabele D, Gwin K, et al. Expression of the oncofetal protein IGF2BP3 in endometrial clear cell carcinoma: assessment of frequency and significance. Hum Pathol. 2013;44:1508\u201315.","journal-title":"Hum Pathol"},{"key":"1045_CR32","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1038\/onc.2015.410","volume":"35","author":"R Mizutani","year":"2016","unstructured":"Mizutani R, Imamachi N, Suzuki Y, Yoshida H, Tochigi N, Oonishi T, et al. Oncofetal protein IGF2BP3 facilitates the activity of proto-oncogene protein eIF4E through the destabilization of EIF4E-BP2 mRNA. Oncogene 2016;35:3495\u2013502.","journal-title":"Oncogene"},{"key":"1045_CR33","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/jid.2014.480","volume":"135","author":"YS Sheen","year":"2015","unstructured":"Sheen YS, Liao YH, Lin MH, Chu CY, Ho BY, Hsieh MC, et al. IMP-3 promotes migration and invasion of melanoma cells by modulating the expression of HMGA2 and predicts poor prognosis in melanoma. J investigative Dermatol. 2015;135:1065\u201373.","journal-title":"J investigative Dermatol"},{"key":"1045_CR34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ccell.2019.12.007","volume":"37","author":"D Hanniford","year":"2020","unstructured":"Hanniford D, Ulloa-Morales A, Karz A, Berzoti-Coelho MG, Moubarak RS, S\u00e1nchez-Sendra B, et al. Epigenetic Silencing of CDR1as Drives IGF2BP3-Mediated Melanoma Invasion and Metastasis. Cancer Cell. 2020;37:55\u201370.e15.","journal-title":"Cancer Cell"},{"key":"1045_CR35","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.canlet.2019.02.008","volume":"450","author":"F Ma","year":"2019","unstructured":"Ma F, Liu X, Zhou S, Li W, Liu C, Chadwick M, et al. Long non-coding RNA FGF13-AS1 inhibits glycolysis and stemness properties of breast cancer cells through FGF13-AS1\/IGF2BPs\/Myc feedback loop. Cancer Lett. 2019;450:63\u201375.","journal-title":"Cancer Lett"},{"key":"1045_CR36","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/s41419-021-04245-y","volume":"12","author":"T Liu","year":"2021","unstructured":"Liu T, Hu J, Han B, Tan S, Jia W. A positive feedback loop of lncRNA-RMRP\/ZNRF3 axis and Wnt\/\u03b2-catenin signaling regulates the progression and temozolomide resistance in glioma. Cell Death Dis. 2021;12:952.","journal-title":"Cell Death Dis"},{"key":"1045_CR37","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41419-021-03489-y","volume":"12","author":"X Xie","year":"2021","unstructured":"Xie X, Lin J, Fan X, Zhong Y, Chen Y, Liu K, et al. LncRNA CDKN2B-AS1 stabilized by IGF2BP3 drives the malignancy of renal clear cell carcinoma through epigenetically activating NUF2 transcription. Cell Death Dis. 2021;12:201.","journal-title":"Cell Death Dis"},{"key":"1045_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-00327-0","volume":"7","author":"AK Seitz","year":"2017","unstructured":"Seitz AK, Christensen LL, Christensen E, Faarkrog K, Ostenfeld MS, Hedegaard J, et al. Profiling of long non-coding RNAs identifies LINC00958 and LINC01296 as candidate oncogenes in bladder cancer. Sci Rep. 2017;7:395.","journal-title":"Sci Rep"},{"key":"1045_CR39","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13045-019-0839-x","volume":"13","author":"X Zuo","year":"2020","unstructured":"Zuo X, Chen Z, Gao W, Zhang Y, Wang J, Wang J, et al. M6A-mediated upregulation of LINC00958 increases lipogenesis and acts as a nanotherapeutic target in hepatocellular carcinoma. J Hematol Oncol. 2020;13:5.","journal-title":"J Hematol Oncol"},{"key":"1045_CR40","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.canlet.2018.12.017","volume":"446","author":"S Chen","year":"2019","unstructured":"Chen S, Chen JZ, Zhang JQ, Chen HX, Qiu FN, Yan ML, et al. Silencing of long noncoding RNA LINC00958 prevents tumor initiation of pancreatic cancer by acting as a sponge of microRNA-330-5p to down-regulate PAX8. Cancer Lett. 2019;446:49\u201361.","journal-title":"Cancer Lett"},{"key":"1045_CR41","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1172\/JCI96218","volume":"128","author":"W He","year":"2018","unstructured":"He W, Zhong G, Jiang N, Wang B, Fan X, Chen C, et al. Long noncoding RNA BLACAT2 promotes bladder cancer-associated lymphangiogenesis and lymphatic metastasis. J Clin Investig. 2018;128:861\u201375.","journal-title":"J Clin Investig"},{"key":"1045_CR42","doi-asserted-by":"crossref","unstructured":"Liu X, Li L, Bai J, Li L, Fan J, Fu Z, et al. Long noncoding RNA plasmacytoma variant translocation 1 promotes progression of colorectal cancer by sponging microRNA-152-3p and regulating E2F3\/MAPK8 signaling. Cancer Sci. 2021;113:109\u2013119.","DOI":"10.1111\/cas.15113"},{"key":"1045_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01232-3","volume":"19","author":"X He","year":"2020","unstructured":"He X, Chai P, Li F, Zhang L, Zhou C, Yuan X, et al. A novel LncRNA transcript, RBAT1, accelerates tumorigenesis through interacting with HNRNPL and cis-activating E2F3. Mol Cancer. 2020;19:115.","journal-title":"Mol Cancer"},{"key":"1045_CR44","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1177\/15353702211035693","volume":"246","author":"S Jusino","year":"2021","unstructured":"Jusino S, Rivera-Rivera Y, Chard\u00f3n-Col\u00f3n C, Ruiz-Justiz AJ. E2F3 drives the epithelial-to-mesenchymal transition, cell invasion, and metastasis in breast cancer. Exp Biol Med (Maywood, NJ). 2021;246:2057\u201371.","journal-title":"Exp Biol Med (Maywood, NJ)"},{"key":"1045_CR45","doi-asserted-by":"publisher","first-page":"6450","DOI":"10.1158\/0008-5472.CAN-11-0364","volume":"71","author":"T Tsuruta","year":"2011","unstructured":"Tsuruta T, Kozaki K, Uesugi A, Furuta M, Hirasawa A, Imoto I, et al. miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer. Cancer Res. 2011;71:6450\u201362.","journal-title":"Cancer Res"},{"key":"1045_CR46","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1093\/nar\/gkw104","volume":"44","author":"Y Zhou","year":"2016","unstructured":"Zhou Y, Zeng P, Li YH, Zhang Z, Cui Q. SRAMP: prediction of mammalian N6-methyladenosine (m6A) sites based on sequence-derived features. Nucleic acids Res. 2016;44:e91.","journal-title":"Nucleic acids Res"},{"key":"1045_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01359-x","volume":"20","author":"F Xie","year":"2021","unstructured":"Xie F, Huang C, Liu F, Zhang H, Xiao X, Sun J, et al. CircPTPRA blocks the recognition of RNA N(6)-methyladenosine through interacting with IGF2BP1 to suppress bladder cancer progression. Mol Cancer. 2021;20:68.","journal-title":"Mol Cancer"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-022-01045-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-022-01045-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-022-01045-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T15:34:10Z","timestamp":1669304050000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-022-01045-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,8]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1045"],"URL":"https:\/\/doi.org\/10.1038\/s41420-022-01045-x","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,8]]},"assertion":[{"value":"3 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"279"}}